Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
News
Pricing
Company
About Musaffa
Investors
Build with us
Is Scribe Therapeutics Inc Stock Halal?
Shariah Compliance Analysis of SCTX Stock
No. As of September 2026, Scribe Therapeutics Inc (SCTX) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Scribe Therapeutics Inc does not pass Musaffa's business and financial screening criteria.
Scribe Therapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Alameda, California. The company went IPO on 2026-07-24. Scribe Therapeutics, Inc. is a clinical-stage biotechnology company engineering purpose-built in vivo CRISPR technologies designed to extend healthy lifespan through disease prevention and durable therapeutic intervention. The company focuses on cardiovascular and metabolic (CVM) diseases with initial programs to address the key drivers of atherosclerotic cardiovascular disease (ASCVD). The firm's lead product candidate, STX-1150, is an epigenetic silencing therapy that is based on its ELXR technology and is designed to durably lower LDL-C for years to decades by repressing the expression of PCSK9, a genetically and clinically validated target. STX-1150 is designed to achieve long-lasting therapeutic benefit without permanently altering the underlying DNA sequence. Its pipeline also includes STX-1200 and STX-1400, target two additional lipid drivers of ASCVD, elevated Lp(a) and severely high triglycerides, by editing the LPA and APOC3 genes, respectively.
SCTX Shariah Compliance
Screening Methodology: AAOIFI
As of September 2026, Scribe Therapeutics Inc is classified as not halal.
NOT HALALScribe Therapeutics Inc (SCTX) Chart
Fetching Price Chart...
Financial Metrics & Statements of Scribe Therapeutics Inc (SCTX)
FAQ's for Scribe Therapeutics Inc (SCTX)
- As of September 2026, Scribe Therapeutics Inc SCTX is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Scribe Therapeutics Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Scribe Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Scribe Therapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Scribe Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Scribe Therapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Scribe Therapeutics Inc (SCTX)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
